Valid

YY/T 1292.1-2015Test for reproductive and developmental toxicity of medical devices - Part 1: Screening test (English PDF)

医疗器械生殖和发育毒性试验 第1部分:筛选试验

Preview PDF

This is a limited preview

Buy now to download the full PDF (15 pages)

Need quotation for your management?

Get a formal quotation for YY/T 1292.1-2015 in 30 minutes.

Issued by

NMPA

Level / Type

Industry · Recommended

Issue date

March 2, 2015

Implementation date

January 1, 2016

Scope

YY/T 1292.1-2015 is the English-translated version of 医疗器械生殖和发育毒性试验 第1部分:筛选试验.

YY/T 1292.1-2015 is the Chinese pharmaceutical industry standard that gives the screening test for the reproductive and developmental toxicity of a medical device or material.

It is the first part of the YY/T 1292 series and sets out the animals and their dosing with the device or its extract, the mating and the period covered, the observations on fertility, on the course of the pregnancy and on the offspring, and the way the result is interpreted. Issued on 2 March 2015, it has applied since 1 January 2016.

Found what you need?

Document preview — YY/T 1292.1-2015

National Standard of the People's Republic of China

ICS
11.040.01
Classification
C 30

Issued by: National Medical Products Administration of the People's Republic of China

Contents

  • Foreword
  • Introduction
  • 1 Scope
  • 2 Normative references
  • 3 Terms and Definitions

Foreword

YY/T 1292 "Medical Devices reproductive and developmental toxicity test" intended to divide part of the publication, currently plans to release The following components.

--- Part 1. Screening test;

--- Part 2. embryo toxicity test; This section YY/T 1292 Part 1. This section drafted in accordance with GB/T 1.1-2009 given rules.

Some elements of this document may involve patents. Release mechanism of the present document does not assume responsibility for the identification of these patents.

Introduction

Detect potential reproductive GB/T 16886.3 given and test methods for developmental toxicity substances are the Organization for Economic Cooperation and Development (OECD) method "chemical testing guidelines" set forth, but these methods are made for the development of chemical properties, but did not give details Test procedure, and therefore not suitable for the direct detection of medical devices or materials. The original part of the basic reference test method OECD421 Then, and according to the characteristics of medical devices or materials test methods were appropriate modifications, it provides detailed test procedure can be used as

GB/T 16886.3 to one standard method of reproductive and developmental toxicity test.

Reproductive medical devices or materials and developmental toxicity potential has a very important influence on human health. Especially for medical resorbable Devices containing leachables or medical devices. GB/T 16886.3 recommended the following medical devices or materials, in the absence of exclusion of reproductive and developmental toxicity Lower risk evidence, consider reproductive and developmental toxicity test.

a) with possible reproductive tissue or embryo (fetus) direct long-term or permanent contact devices, resorbable or leachable material (such as silicon condensate Gel breast implants);

b) storage of medical devices.

This section used to design the evaluation of medical devices or material female and/or male reproductive function on the test, such as gonadal function, mating Behavior, pregnancy, fetal development and childbirth, the results of the information obtained is limited.

Due to the limitations of the impact of the test sample preparation and test method validation, etc., in determining the reproductive and developmental toxicity test Previously, the need for full consideration of GB/T 16886.1 and GB/T 16886.18 requirements. Need as reproductive and made use of in the evaluation of medical devices Fertility risk of toxicity on the basis of the decision to be tested shall be demonstrated.

Of resorbable or leachable medical devices containing filter material, if there is in the absorption, metabolism, distribution and research sufficiently reliable data, or Medical device materials were identified in extracts of all the ingredients or when no reproductive and developmental toxicity, no longer need to be tested. Medical devices After mechanical biological acceptable conduct risk assessment, risk such as reproductive and developmental toxicity has been ruled out, you do not need the test.

1 Scope

This section YY/T 1292 specifies the medical device or material reproductive and developmental toxicity screening test methods.

This section applies to medical devices or materials reproductive and developmental toxicity test.

2 Normative references

The following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein Member. For undated references, the latest edition (including any amendments) applies to this document.

GB/T 16886.1 Biological evaluation of medical devices - Part 1. Evaluation of the risk management process and Test

GB/T 16886.2 Biological evaluation of medical devices - Part 2. Animal welfare requirements

GB/T 16886.3 Biological evaluation of medical devices - Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicity

GB/T 16886.12 Biological evaluation of medical devices - Part 12. Sample preparation and reference materials

3 Terms and Definitions

GB/T 16886.1, GB/T 16886.3 and GB/T 16886.12 defined and the following terms and definitions apply to this document.

3.1 Reproductive toxicity

The performance of the parental male and female reproductive function or ability to damage and/or harmful effects on the progeny.

3.2 Maternal toxicity

The performance of a specific (direct) or specific (indirect) adverse effects on female pregnant animals.

3.3 Damage impairmentoffertility Fertility

The performance of male or female reproductive function or capability abnormal animal.

3.4 Developmental Toxicity

Reproductive toxicity performance means the offspring before birth, perinatal and after birth as demonstrated structural or functional abnormalities.

3.5 Dose

The dose of the test substance. It expressed per unit of body weight of test animals administered an amount of the test substance (mg/kg), or incorporated into the feed or drinking water Constant concentration.

3.6 The amount of dosage

Including dose, frequency of administration and collectively given period.

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 15 pages — is available in the English PDF.

Referenced standards

Similar standards

How to Download YY/T 1292.1-2015

  1. 1

    Add to cart

    Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.

  2. 2

    Checkout

    Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).

  3. 3

    Instant delivery (0–9 sec)

    Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.

  4. 4

    Invoice included

    A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.

Related Standards

English PDF
15 pages
Instant delivery (0–9 sec)
Invoice included
View Cart

Secure payment via Stripe

Payments accepted

VisaMastercardAmerican ExpressApple PayGoogle PayStripe

YY/T 1292.1-2015

$210.00